Litigation Details for In re: Cellect, LLC (Fed. Cir. 2021)
✉ Email this page to a colleague
In re: Cellect, LLC (Fed. Cir. 2021)
Docket | ⤷ Try a Trial | Date Filed | 2021-12-22 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | 2023-08-28 |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 7,943,788; 8,222,219 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in In re: Cellect, LLC
Details for In re: Cellect, LLC (Fed. Cir. 2021)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-09-13 | 47 | reference patent (U.S. Patent No. 8,222,219) and challenged patent (U.S. Patent No. 7,943,788) were part…of the ’742 patent, the ’369 patent, the ’626 patent, and the ’621 patent are patentably indistinct from…difference in patent term between claims in the reference patents and challenged patents is due to patent term…challenged patents,” individually, “the ’742 patent,” “the ’369 patent,” “the ’626 patent,” and “the …reference patents, render the claims in the ’742 patent, the ’369 patent, and the ’626 patent unpatentable | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |